IHC Solutions

Almac Diagnostic Services offers end-to-end IHC (Immunohistochemistry) biomarker assay support for research and clinical applications, including CTA and CDx development. Our state-of-the-art laboratories are equipped with a broad range of automated staining platforms and advanced digital pathology tools, enabling high-throughput, reproducible analysis and precise interpretation. Delivered within a GCLP, CLIA, and ISO 15189-compliant framework, our IHC services combine scientific rigor with operational flexibility to meet the evolving needs of precision oncology and translational research.

Due to increasing client demand, Almac has recently increased the capacity of our IHC services, and as part of our new laboratory facilities expansion we have created a new dedicated IHC & pathology lab at our Craigavon, UK Headquarters and increased our IHC capacity and instrumentation in our Durham, NC labs in the USA.

Almac can develop and validate custom clinical biomarker assays on IHC platforms or tech transfer in existing IHC assays for clients’ clinical trial needs. We can also provide associated global clinical trial testing.

Almac offers solutions from leading IHC staining technology providers including Leica, Roche Ventana and Agilent DAKO instruments.